The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Icosapent Ethyl
Icosapent Ethyl · ICOSAPENT ETHYL 1 g/1 · Capsule, Liquid Filled · Oral · AvKARE
NDC 42291-0046-12 · 120 CAPSULE, LIQUID FILLED in 1 BOTTLE · ANDA · View full market →
One drug, every price
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
ⓘ How this was built
Data sources
- CMS NADAC (pharmacy acquisition, weekly)
- CMS Part B ASP quarterly payment limits
- CMS Maximum Fair Prices (IRA negotiated, NDC-level)
- Medicare Part D Spending by Drug (data.cms.gov, name-matched)
- VA FSS / Big4 federal contract prices (va.gov, twice monthly)
- ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
- California SB-17 WAC filings (list price, per package)
Method
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- Part D plans paid (avg)$1.44per dosage unitgross, before rebates — matched by drug name · 2024
- Federal contracts pay (FSS)$0.8418per unitAvKare, LLC · Dec 24, 2024
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$121.40
Reported to Texas DSHS · 2026 annual filing · AvKare
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for icosapent ethyl (oral solid) in the next 90 days
sole-source market · 1 Class I/II recall(s) in 12 months
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA209525
- TE code
- AB
- Approval date
- Sep 11, 2020
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Icosapent Ethyl (Capsule, Liquid Filled)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Epic Pharma, Llc | ICOSAPENT ETHYL 1 g/1 | Jul 15, 2026 | Sep 3, 2026 |
| Bryant Ranch Prepack | ICOSAPENT ETHYL 1 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Epic Pharma, Llc | ICOSAPENT ETHYL .5 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Softgels Inc. | ICOSAPENT ETHYL 1 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals, Inc. | ICOSAPENT ETHYL 1 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals, Inc. | ICOSAPENT ETHYL 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AvKARE | ICOSAPENT ETHYL 1 g/1 | Jul 15, 2026 | Jul 29, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Icosapent Ethyl — NDC 42291-0046-12," retrieved September 3, 2026, https://drugdashboards.com/drug/42291004612.
Free to cite with attribution — see how the data is put together.